Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Supported by Plan International, the partnership will help treat over 1,000 children annually
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
Subscribe To Our Newsletter & Stay Updated